Cargando…

Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients

Lung Squamous Cell Carcinoma (LUSC) is an aggressive malignancy with limited therapeutic options. The response to immune therapy is a determining factor for the prognosis of LUSC patients. This study aimed to develop a reliable immune-related prognostic signature in LUSC. We extracted gene expressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xianyu, Zhao, Deze, Shan, Yunhan, Cui, Weifang, Xie, Qun, Jiang, Junjie, Peng, Wei, Zhang, Chunfang, Duan, Chaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715950/ https://www.ncbi.nlm.nih.gov/pubmed/36456645 http://dx.doi.org/10.1038/s41598-022-23140-w

Ejemplares similares

Recognition of immune-related tumor antigens and immune subtypes for mRNA vaccine development in lung adenocarcinoma
por: Zhao, Deze, et al.
Publicado: (2022)

Plasma tRNA-derived small RNAs signature as a predictive and prognostic biomarker in lung adenocarcinoma
por: Wang, Jun, et al.
Publicado: (2022)

tRNA-derived small RNAs: novel regulators of cancer hallmarks and targets of clinical application
por: Li, Xizhe, et al.
Publicado: (2021)

tRNA Modifications and Modifying Enzymes in Disease, the Potential Therapeutic Targets
por: Cui, Weifang, et al.
Publicado: (2023)

Circadian gene ARNTL initiates circGUCY1A2 transcription to suppress non-small cell lung cancer progression via miR-200c-3p/PTEN signaling
por: Zhao, Deze, et al.
Publicado: (2023)

Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
por: Huang, Qiang, et al.
Publicado: (2022)

Functions and mechanisms of long noncoding RNAs in lung cancer
por: Peng, Zhenzi, et al.
Publicado: (2016)

XBP1- IGFBP3 Signaling Pathway Promotes NSCLC Invasion and Metastasis
por: Luo, Qingxi, et al.
Publicado: (2021)

Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma
por: Qiu, Yu, et al.
Publicado: (2020)

Identification and Validation of a Prognostic Immune-Related Gene Signature in Esophageal Squamous Cell Carcinoma
por: Xiong, Kai, et al.
Publicado: (2022)

Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival
por: Chen, Rui-Lian, et al.
Publicado: (2020)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Systemic Analysis on the Features of Immune Microenvironment Related to Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Su, Kaixin, et al.
Publicado: (2022)

An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020)

Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma
por: Wang, Wentao, et al.
Publicado: (2023)

Vasculogenic mimicry in carcinogenesis and clinical applications
por: Luo, Qingxi, et al.
Publicado: (2020)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma
por: Li, Han, et al.
Publicado: (2022)

Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis‐related genes
por: Diao, Xiayao, et al.
Publicado: (2021)

Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma
por: Li, Liang, et al.
Publicado: (2021)

Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma
por: Fang, Jiayu, et al.
Publicado: (2021)

Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
por: Zhang, Yan, et al.
Publicado: (2021)

Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Li, Na, et al.
Publicado: (2021)

Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma
por: Zhao, Xinyuan, et al.
Publicado: (2020)

A novel immunogenomic prognostic signature in lung squamous carcinoma
por: Hou, Jili, et al.
Publicado: (2021)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Identification and validation of seven RNA binding protein genes as a prognostic signature in oral cavity squamous cell carcinoma
por: Huang, Zijing, et al.
Publicado: (2021)

Identification and Validation of a GPX4-Related Immune Prognostic Signature for Lung Adenocarcinoma
por: Feng, Zhenxing, et al.
Publicado: (2022)

Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2022)

Identification and Validation of a Hypoxia-Immune-Based Prognostic mRNA Signature for Oral Squamous Cell Carcinoma
por: Lv, Shaohua, et al.
Publicado: (2022)

Identification of an immune prognostic 11-gene signature for lung adenocarcinoma
por: Yang, Tao, et al.
Publicado: (2021)

Construction and validation of a seven-microRNA signature as a prognostic tool for lung squamous cell carcinoma
por: Gan, Zuhuan, et al.
Publicado: (2019)

Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma
por: Yu, Yunhu, et al.
Publicado: (2021)

Prognostic signature related to the immune environment of oral squamous cell carcinoma
por: Hua, Yingjie, et al.
Publicado: (2022)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

Immune landscape and prognostic immune-related signature in KRAS-mutated lung adenocarcinoma
por: Peng, Xinyi, et al.
Publicado: (2023)

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
por: Cui, Mengjing, et al.
Publicado: (2022)

Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma
por: Zhang, Yiping, et al.
Publicado: (2023)

Corrigendum: Development and validation of a m(6)A -regulated prognostic signature in lung adenocarcinoma
por: Chen, Yaxin, et al.
Publicado: (2023)

Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
por: Wu, Pancheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rfl9tsf1v85oqj2v8f2h1e2hm0